Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 22, pseudogene (RNU1-22P) is a non-coding RNA gene of the pseudogene class in humans[1][4]. It is part of the extensive U1 small nuclear RNA (snRNA) pseudogene family. The canonical functional U1 snRNA genes play an essential role in splicing by recognizing the 5’ splice site of pre-mRNAs and participating as a core spliceosome component[3][5]. However, RNU1-22P lacks the ability to produce a functional U1 snRNA due to sequence disruptions typical of pseudogenes[5]. Historically, such U1 snRNA pseudogenes were classified as nonfunctional, but recent research indicates that some pseudogenes can be transcribed and may regulate gene expression via RNA-based mechanisms, such as acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges[2][5]. For RNU1-22P specifically, there is no direct evidence of biological or therapeutic targeting relevance, nor association with disease, biomarkers, or drug interactions, but its broader family is under investigation for regulatory roles in gene expression and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 22, pseudogene (RNU1-22P).